Diagnosis of mycosis fungoides following administration of dupilumab for misdiagnosed atopic dermatitis. Acta Derm Venereol 2019; 99: 818-9. 19. Espinosa ML, Nguyen MT, Aguirre AS, et al. Progression ...

Odronextamab (CD20xCD3) for lymphoma: Ordspono™ (odronextamab ... Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®. Before using DUPIXENT, tell your ...

Odronextamab (CD20xCD3) for lymphoma: Ordspono™ (odronextamab ... Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®. Before using DUPIXENT, tell your healthcare ...

It was originally intended to treat non-Hodgkin’s lymphoma but has been repurposed ... Casanovas said: “Dupilumab is paving the way in pricing for other biologics to enter the market.

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...

Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

Dupixent (dupilumab) is now used to treat over a million patients globally. The recent approval and launch in chronic obstructive pulmonary disease (COPD) have had a successful start, with ...

Several nonprofit organizations, such as the American Cancer Society, Cancer Care, CLL Society, and the Leukemia and Lymphoma Society provide ways for people with CLL to connect with others.

Dupixent ® (dupilumab) is now used to treat over a million patients globally. The recent approval and launch in chronic obstructive pulmonary disease (COPD) has had a successful start ...

coholding a patent for resiquimod for treatment of cutaneous T-cell lymphoma; and serving as Deputy Editor for the Journal of Investigative Dermatology, as Chief Medical Editor for Healio ...